FDA Investigator Stacey S Degarmo

Stacey S Degarmo has conducted inspections on 87 sites in 6 countries as of 14 Sep 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
87
Last Inspection Date:
14 Sep 2016
Investigator Role:
FDA Investigator
Redica ID:
100000516
Countries of Inspections:
Canada, United States of America, Belgium, India, Denmark, Malta
FDA Investigators that have inspected at least one site in common with Stacey S Degarmo:
Abby E Pelletier, Abdur Rafay Shareef, Ademola O Daramola, Aimee Cunningham, PhD, Aireen V Mendoza, Alan R Condon, Alice C Silva, Alice Canty, Allison A Rodriguez, Almaris N Alonso, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Amy N Chen, Anastasia M Shields, Andre S Lamontagne, Andrew Le, Andrew M Barlow, Angela E Glenn, Angela J Davis, Anissa M Cheung, Anne E Carpenter, Annet R Rajan, Anthony C Warchut, Anthony W Thomas, Arie C Menachem, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashley M Whitehurst, Barbara M Frazier, Bo Chi, PhD, Bradley D Newsad, Brenda P King, Brenda W Uratani, PhD, Brentley S Collins, Burnell M Henry, Byungja E Marciante, Calvin B Koerner, Camerson E Moore, Candace Y Gomez Broughton, Carla C Cummins, Carla C Tuite, Carlos Chavez, Cassandra L Abellard, CDR Jeremy L Wally, PhD, Charanjeet Jassal, Charlotte Hinkle, Cheryl A Clausen, Chiang Syin, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christopher Downey, PhD, Constance Desimone, Courtney N Long, Crystal Monroy, Cynthia A Palmer, Cynthia Jim, CSO, Cynthia Whitmarsh, Daniel L Zheng, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Dawn M Braswell, Deborah J Parris, Demitria J Xiradakis, Dien N Nguyen, Donald C Obenhuber, PhD, Dorothy W Lee, Douglas S Joslin, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Ekaterina Allen, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Felix Maldonado, Garry H Stewart, Gary J Hagan, Gene D Arcy, George M Ibrahim, George T Allen, Jr, Gerard D Difiore, Gunther Boekhoudt, PhD, Helen B Ricalde, Helen Verdel, Holly Brevig, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Liubicich, James W Whitney, Jamie S Mathews, Jason A Rossi, Javier O Vega, Jawaid Hamid, Jayaleka J Amarasinghe, Jee Chung, PhD, Jennifer C Adams, Jennifer T Szymanski, Jianming Li, Joan A Loreng, John A Sciacchitano, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan G Matrisciano, José E Meléndez, Jose R Hernandez, Joyce A Kellett, Joyce A Rockwell, Julie D Bringger, Junho Pak, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Kara D Dobbin, Karen A Briggs, Karen Mcnabb Noon, Karishma G Gopaul, Katherine D Adams, Kathleen E Mcafoose, Kathleen R Jones, PhD, Katie L Korchinski, Kenneth H Williams, Kent A Conforti, Kristina J Donohue, Kristina M Joyce, L Norwood, Lane V Christensen, PhD, Larry K Austin, Lauren M Lawrance, Laurie B Frazier, Laurie Graham, Lawrence J Stringer, LCDR Debra Emerson, Lei Zhang, PhD, Leiyun Boone, PhD, Leo B Zadecky, Lewis K Antwi, Li Yun Huang, Lori A Holmquist, Lori M Newman, Louis Christy, M Pedgen, Maotang Zhou, PhD, Margaret E Walsh, Margaret M Sands, Maria Joselopez Barragan, PhD, Marie F Morin, Mariza M Jafary, Mark C Lookabaugh, Mark E Parmon, Mark R Mcclain, Marlene G Swider, Martha T Olone, Mary Jeanet Mcgarry, Matthew B Casale, Matthew C Watson, Matthew D Silverman, Maura Rooney, Maxwell Van Tassell, PhD, Maya M Davis, Megan A Haggerty, Meredith L Miller, Michael J Casey, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michele L Forster, PhD, Michelle M Noe Varga, Michelle Yclark Stuart, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Monique C Lo, Mra Greenc, Nabil Nakhoul, Nailing Zhang, Nancy T Waites, Nealie C Newberger, Nichole B Murphy, Nicole K Trudel, Obinna R Echeozo, Ogechi C Nna, Osama A Khatib, Pal S Mayasandra, Pamela L Lee, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia F Hughes, PhD, Paul L Bellamy, Paul Mouris, Paul P Geraci, Paula A Trost, Paula M Laplant, Pete Amin (Pankaj), Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Pratik S Upadhyay, DDC, Priscilla M Pastrana, Qing Joanna Zhou, PhD, Raeann R Wu, Ramon E Martinez, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Richard A Abate, Richard B Mcaroy, Richard H Penta, Richard L Friedman, Richard Ledwidge (nmi), PhD, Richard W Thornton, Robert D Tollefsen, Robert J Doyle, Robert J Martin, Robert O'brian, Rory K Geyer, Rose Ashley, S Lori Brown, PhD MPH, Saleem A Akhtar, Samuel J Arsenault, Sandra A Hughes, Sandra P White, Sangeeta M Khurana, PhD, Satheesh Thomas, Scott R Nichols, PhD, Sean R Marcsisin, Seth A Mailhot, Sharon K Thoma, PharmD, Shirley S Wen, Simone E Pitts, Slater K Bartlett, Stephen C King, Stephen C Smith, Stephen J Mottola, Stephen R Souza, Steven Fong, MS, PhD, Steven P Donald, Sunita Pandey, Susan D Yuscius, Susanne M Richardson, MS RAC, Suzanne M Healy, Svetlana A Shestopal, Sylvia A Craven, Teddy Tom, Thomas J Arista, Thomas W Nerney, Tonia F Bernard, Towanda L Terrell, Valentino Fiorella, Victor J Gangi, Victoria M Daddeo, Vijaya L Simhadri, Walter N Lange, Wayne E Seifert, Wendy A Johnecheck, William Hallett, PhD, William J Leonard, Xiaokuang Lai, PhD, Yanming An, PhD, Yetao Jin, PhD, Ying Xin Fan, PhD, Yumi J Hiramine, Ze Peng, Zhongren Wu, Ziyang Su, PhD

Stacey S Degarmo's Documents

Publish Date Document Type Title
June, 2015 FDA 483 AbbVie Bioresearch Center - Form 483, 2015-06-11
September, 2014 FDA 483 Northern New England Compounding Pharmacy LLC - Form 483, 2014-09-30
September, 2014 FDA 483 Response Northern New England Compounding Pharmacy LLC - Form 483R, 2015-04-22
February, 2016 FDA 483 Anderson Holdings Inc. - Form 483, 2016-02-19
August, 2012 FDA 483 Tender Corporation - Form 483, 2012-08-17
March, 2014 FDA 483 NYPRO Finpack Clinton - Form 483, 2014-03-21
December, 2011 FDA 483 Citra Labs, LLC - Form 483, 2011-12-09
July, 2010 EIR Ameridose, LLC - EIR, 2010-07-08
March, 2014 EIR NYPRO Finpack Clinton - EIR, 2014-03-21
April, 2014 FDA 483 PLZ Corp - Form 483, 2014-06-04
January, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-01-29
September, 2011 FDA 483 CIPLA LIMITED - Form 483, 2011-09-22
September, 2011 FDA 483 Aurobindo Pharma Limited - Form 483, 2011-09-08
June, 2016 FDA 483 Avista Pharma Solutions, Inc. dba Cambrex - Form 483, 2016-06-15
June, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-06-02
September, 2016 FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2016-09-30
August, 2015 FDA 483 Mytilini Enterprises LLC dba Bedford Pharmacy Inc. - Form 483, 2015-08-28
October, 2012 FDA 483 New England Compounding Pharmacy, Inc. - Form 483, 2012-10-26
February, 2016 FDA 483 Response Anderson Holdings Inc. - Form 483R, 2016-02-29
August, 2011 EIR AMAG Pharmaceuticals, Inc. - EIR, 2011-08-03
January, 2014 FDA 483 Lyophilization Services Of New England, Inc. (LSNE) - Form 483, 2014-01-29
March, 2015 FDA 483 DANIPHARM A/S - Form 483, 2015-03-04
April, 2015 EIR Lyophilization Services Of New England, Inc. (LSNE) - EIR, 2015-04-24
January, 2010 FDA 483 The Gillette Company - Form 483, 2010-01-29
September, 2013 EIR Genzyme Corporation - EIR, 2013-09-30
March, 2016 FDA 483 Cambridge Isotope Laboratories, Inc. - Form 483, 2016-03-25
October, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-10-22
July, 2014 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2014-07-10
April, 2010 FDA 483 Lonza Biologics, Inc. - Form 483, 2010-04-21
June, 2016 FDA 483 Response Avista Pharma Solutions, Inc. dba Cambrex - Form 483R, 2016-10-04
February, 2012 FDA 483 Bayscience Formulators, LLC - Form 483, 2012-02-29
September, 2010 EIR Biogen, Inc. - EIR, 2010-09-08
July, 2010 EIR Ameridose, LLC - EIR, 2010-07-15
January, 2013 FDA 483 BFS Pharma, Inc. - Form 483, 2013-01-17
June, 2015 EIR AbbVie Bioresearch Center - EIR, 2015-06-11
April, 2011 FDA 483 Sunovion Pharmaceuticals Inc. - Form 483, 2011-04-20
July, 2016 FDA 483 Curia Massachusetts, Inc. - Form 483, 2016-07-13
August, 2011 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2011-08-03
August, 2014 FDA 483 PHARMARON MANUFACTURING SERVICES (US) LLC - Form 483, 2014-08-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more